Crizotinib shows responses in pediatric ALCL and IMT

FROM JOURNAL OF CLINICAL ONCOLOGY Treatment with the ALK-inhibitor crizotinib produced high response rates ...

FDA approves first spironolactone oral suspension

The Food and Drug Administration has approved CaroSpir, the first oral suspension form of ...

FDA committee recommends approval of tofacitinib for PsA

Convinced largely by encouraging efficacy data, the Food and Drug Administration’s Arthritis Advisory Committee ...

Abilify Maintena OK’d by FDA for adults with bipolar I disorder

The Food and Drug Administration has approved a monthly injectable formulation of aripiprazole, (Abilify ...

FDA approves nivolumab for metastatic CRC

The Food and Drug Administration has granted accelerated approval to checkpoint inhibitor nivolumab for ...

Ibrutinib becomes first FDA-approved treatment for chronic GVHD

Ibrutinib (Imbruvica) added another notch on its indications belt with its Aug. 2 approval ...

FDA advisory committee approves safety of new hepatitis B vaccine for adults

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee approved licensure ...

New monotherapy approved for partial-onset seizures

The U.S. Food and Drug Administration has approved perampanel (Fycompa) for monotherapy treatment of ...